Bullous pemphigoid and pemphigus vulgaris: Correlated behaviour of serum VEGF, sE-selectin and TNF-alpha levels

Journal of Biological Regulators and Homeostatic Agents

Volumn 11, Issue 4, 1997, Pages 148-153

  Ameglio, F ^a   D'Auria, L ^a   Cordiali Fei, P ^a   Mussi, A ^a   Valenzano, L ^a   D'Agosto, G ^a   Ferraro, C ^a   Bonifati, C ^a   Giacalone, B ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Anti epithelium antibodies; Bullous pemphigoid; Pemphigus vulgaris; sE selectin; TNF alpha; VEGF

Indexed keywords

CELL ADHESION MOLECULE; CELL MEMBRANE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PEMPHIGOID; PEMPHIGUS VULGARIS; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SKIN DEFECT; SKIN DISEASE;

EID: 0031432387     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kian-Aung U, Haskard DO, Poston RN, Thornhill MII, Lee TE. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 1991; 146: 521-8.
2. Leeuwenberg JFM, Smeets EF, Neefjes JJ, et al. E-Selectin and Intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. J Immunol 1992; 77: 543-9.
3. Ameglio F, Bonifati C, Carducci M et al. Serum soluble E-selectin levels decrease early during effective therapy in psoriatic patients. Eur J Dermatol 1995; 5: 512-5.
4. Bonifati C, Trento E, Carducci M, et al. Soluble E-selectin levels and soluble tumor necrosis factor receptor (60 kD) serum levels in patients with psoriasis. Dermatology 1995; 190: 128-31.
5. Mussi A, Bonifati C, Carducci M, et al. Serum TNF-alpha-levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents, 1997; 11: 115-8.
6. Saurat JH. Maladies bulleuses. In: Dermatologie et Venereologie, 2nd ed 1990, Masson, Paris, Milan, Barcelona and Dakota, pp 213-76.
7. Fabbri P Dermatosi da alterata immunoregolazione. Malattie autoimmuni cutanee. In: Immunodermatologia, 1st Ed, 1993, ISED, Brescia, pp 224-79.
8. Sams WM, Gammon WR. Mechanisms of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol 1982; 6: 431-49.
9. Shirakata Y, Shiraishi S, Sayama K, Mikj Y. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol 1990; 17: 661-6.
10. D'Auria L, Cordiali-Fei P, Pietravalle M, et al. The serum levels of sE-selectin are increased in patients with bullous pemphigoid or pemphigus vulgaris. Correlation with the number of skin lesions and recovery after corticosteroid therapy. Br J Dermatol 1997; 137: 59-64.
11. D'Auria, Bonifati C, Mussi A, et al. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumor necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlated with disease activity. Eur Cytokine Netw, 1997, 8: 383-7.
12. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin-6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996; 271: 736-41.
13. Groves RW, Allen MH, Ross EL, Barker JN, Mac Donald DM. Tumor necrosis factor-alpha is proinflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol, 1995; 132:345.
14. Brown LF, Harrist TJ, Yeo KT et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 1995; 104: 744-9.
15. Snedecor GW, Cochran WG. Statistical methods. 6th edition, 1967, The Iowa State University Press, Ames, USA.
16. Hughes J, Rees AJ, Cashman SJ. Soluble forms of vascualr adhesion molecules, E-Selectin, ICAM-1 and VCAM-1: pathological significance. Ann NY Acad Sci 1992; 667; 324-31.
17. Groves RW, Allen MH, Barker JNWN, Haskard DO, Macdonald DM. Endothelial leukocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 1991; 124: 117-23.
18. Kats AM, Rosenthal D, Sauder DN. Cell adhesion molecules. Structure, function and implication in a variety of cutaneous and other pathologic conditions. Inte J Deramtol 1991; 30: 153-60.
19. Hirai S, Kageshita T, Kimura T, et al. Soluble intercellular adehsion molecule-1 and soluble E-selectin levels in patients with atopic dermatitis. Br J Dermatol 1996; 134: 657-61.
20. Kobayashi T, Hashimoto S, Imai K. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol 1994; 96: 110-5.
21. Machold KP, Kiener HP, Graninger W, Graninger WB. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1993; 68: 74-8.
22. Chorzelski TP, Jablonska S, Beutner EH. Bullous pemphigoid: relationship of immunopathology to clinical findings, p. 337. In Immunopathology of the skin, Beutner EH, Chorzelski TP, Vijay K. 3rd edition, 1987, a Wiley Medical Publication John Wiley & Sons - New York - Chichester - Brisbane - Toronto - Singapore.
23. Krasny SA, Beutner EH, Chorzelski TP. Specificity and sensitivity of indirect and direct immunofluorescence findings in the diagnosis of pemphigus. p. 208. In Immunopathology of the skin. Beutner EH, Chorzelski TP, Vijay K. 3rd edition, 1987, a Wiley Medical Publication John Wiley & Sons -New York - Chichester - Brisbane - Toronto - Singapore.
24. Pigott R, Dillon LP, Hemmingway IH, Gearing AJH. Soluble forms of E-Selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine-activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 548-89.
25. Ameglio F, D'Auria L, Bonifati C, Ferraro C, Mastroianni A, Giacalone B. Pattern of eleven cytokines in blister fluids and sera of patients affected with bullous pemphigoid. Relationships with disease intensity. Br J Dermatol, in press.
26. Grando SA, Glukhenky ET, Drannik GN, Epshtein EV, Kostromin AP, Korostash TA. Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 1989; 125: 925-30.
27. Takematsu H, Ohta H, Tagami H. Determiantion of tumor necrosis factor in blister fluids of bullous pemphigoid. Arch Dermatol Res 1991; 283: 131-2.
28. Schaller J, Giese T, Ladusch M, Haustein UF. Interleukin-2 receptor expression and Interleukin-2 production in bullous pemphigoid. Arch Dermatol Res 1990; 282: 223-6.
29. Endo H, Iwamoto I, Fujita M, Okamoto S, Yoshida S. Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid. Arch Dermatol Res 1992; 284: 312-4.
30. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108: 2369-79.
31. Wintroub BU, Mhim Jr MC, Goetzl EJ, et al. Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. N Engl J Med 1978; 8: 417-21.
32. Lever WF, Schaumburg-Lever G. Non infectious vesicular and bullous diseases, in "Histopathology of the skin", 7th Edition, chapter 7, 125-30; Lippincott JB, Philadelphia.
33. Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ. Keratinocytes as initiators of inflammation Lancet 1991; 337: 211-4.